粗语 发表于 2025-3-25 06:27:08

http://reply.papertrans.cn/2/126/12523/12523-21.png

Charlatan 发表于 2025-3-25 10:45:22

Submitted on: 08 October 2017.
Revised on: 19 January 2018.
Accepted on: 09 March 2018.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

他姓手中拿着 发表于 2025-3-25 12:20:09

Submitted on: 31 August 2017.
Revised on: 21 December 2017.
Accepted on: 13 February 2018.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

抵制 发表于 2025-3-25 19:25:08

http://reply.papertrans.cn/2/126/12523/12523-24.png

CREST 发表于 2025-3-25 22:46:38

Submitted on: 22 January 2013.
Revised on: 28 February 2013.
Accepted on: 25 March 2013.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

MAOIS 发表于 2025-3-26 01:55:19

http://reply.papertrans.cn/2/126/12523/12523-26.png

多产鱼 发表于 2025-3-26 05:51:16

Submitted on: 06 September 2007.
Revised on: 15 October 2007.
Accepted on: 09 December 2007.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

discord 发表于 2025-3-26 12:17:44

Submitted on: 28 April 2021.
Revised on: 30 June 2021.
Accepted on: 27 August 2021.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

暴露他抗议 发表于 2025-3-26 14:51:50

http://reply.papertrans.cn/2/126/12523/12523-29.png

云状 发表于 2025-3-26 20:10:26

http://reply.papertrans.cn/2/126/12523/12523-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊INFLAMMOPHARMACOLOGY 2024/2025影响因子:4.674 (INFLAMMOPHARMACOLOGY) (0925-4692). (IMMUNOLOGY)(免疫学)Science Citation In